GIXEF Stock UPDATES Geologix Expl Inc (GIXEF) 0.0673 08/03/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Geologix Expl Inc (GIXEF) 0.0673 $GIXEF

Geologix Extends Warrants & Reduces Exercise Price
Marketwire - Thu Jul 31, 5:04AM CDT
Geologix Explorations Inc. (TSX: GIX)(FRANKFURT: GF6)(BERLIN: GF6)(STUT: GF6)(MUN: GF6) ("Geologix" or "the Company" announced today that the Company has elected to amend the 6,642,900 warrants it originally issued via a private placement that closed in August 2012. Included in that amount are 425,000 warrants held by insiders of the Company that will not be exercisable on the amended terms until such amendments are approved by shareholders other than such insiders.

Geologix Announces Results of AGM Voting
Marketwire - Fri Jun 27, 3:31PM CDT
Geologix Explorations Inc. (TSX: GIX)(FRANKFURT: GF6)(BERLIN: GF6)(STUT: GF6)(MUN: GF6) ("Geologix", or the "Company" is pleased to announce the results of voting at its Annual General Meeting, which took place on June 18, 2014.

Geologix Sells Non-Core Assets to Argonaut Gold Inc.
Marketwire - Tue May 27, 5:31AM CDT
Geologix Explorations Inc. (TSX: GIX)(FRANKFURT: GF6)(BERLIN: GF6)(STUT: GF6)(MUN: GF6) ("Geologix," the "Company" is pleased to announce the sale of the Company's Nuestra Senora del Carmen II Property to Argonaut Gold Inc. (TSX: AG) ("Argonaut" . Geologix has also executed an assignment to sell Argonaut its Consejo 1 Property. Both properties are located in Mexico. In exchange for these two properties, Argonaut will provide Geologix with total compensation of $600,000 USD.

10-K: DARA BIOSCIENCES, INC.
Edgar Online - Tue Feb 04, 6:02AM CST
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations.

Geologix Explorations: Statement of Tepal Cash Costs to New World Gold Council Standards and Current Metals Price Volatility
Marketwire - Wed Jul 24, 4:30AM CDT
In acknowledgement of the World Gold Council's ("WGC" recently released guidelines regarding both All-In Costs and All-in Sustaining Cash Costs, Geologix Explorations (TSX: GIX)(OTCQX: GIXEF)(FRANKFURT: GF6)(BERLIN: GF6)(STUT: GF6)(MUN: GF6) ("Geologix," the "Company" has elected to present the projected cash costs for its Tepal Project ("Tepal" in Mexico in accordance with these new standards. These cash costs were originally articulated in Tepal's Prefeasibility Report ("PFS" , which was press released on March 19, 2013 and filed with SEDAR on May 7, 2013.

Geologix Explorations Inc is Featured as the Daily Momentum Gainer to Watch on Smallcappower.com
Newsfile Corp - Mon Jul 22, 9:08AM CDT
full story)

Geologix Announces AGM Results
Marketwire - Fri Jul 12, 4:01PM CDT
Geologix Explorations Inc. (TSX: GIX)(OTCQX: GIXEF)(FRANKFURT: GF6)(BERLIN: GF6)(STUT: GF6)(MUN: GF6) ("Geologix" or the "Company" is pleased to announce the results of the election of its directors at the Annual General Meeting of Shareholders held on June 20, 2013.

Geologix Completes $1.0 Million Private Placement
Marketwire - Wed Jul 03, 4:30AM CDT
Geologix Explorations Inc. (TSX: GIX)(OTCQX: GIXEF)(FRANKFURT: GF6)(BERLIN: GF6)(STUT: GF6)(MUN: GF6) ("Geologix" and the "Company" is pleased to announce that the $1,000,000 private placement announced on June 17, 2013 has been successfully completed.

Geologix Sells Silver Cloud Exploration Property in Nevada to Rimrock Gold
Marketwire - Wed May 08, 8:04AM CDT
Geologix Explorations Inc. (the "Company" or "Geologix" (TSX: GIX)(OTCQX: GIXEF)(FRANKFURT: GF6)(BERLIN: GF6)(MUN: GF6)(STUT: GF6) is pleased to announce that it has sold its Silver Cloud Property ("Silver Cloud" in northern Nevada to Rimrock Gold Corp. ("Rimrock Gold" , a Nevada corporation (OTCQB: RMRK).

Geologix Files Tepal Prefeasibility Study Report on SEDAR
Marketwire - Tue May 07, 4:30AM CDT
Geologix Explorations Inc. (the "Company" or "Geologix" (TSX: GIX)(OTCQX: GIXEF)(FRANKFURT: GF6)(BERLIN: GF6)(MUN: GF6)(STUT: GF6) is pleased to announce that the Prefeasibility Study for its Tepal Project in Michoacan State, Mexico has been filed on SEDAR.

Geologix Explorations Announces Results of Positive Prefeasibility Study at Tepal
Marketwire - Tue Mar 19, 4:31AM CDT
Geologix Explorations Inc. (the "Company" or "Geologix" (TSX: GIX)(FRANKFURT: GF6)(BERLIN: GF6)(MUN: GF6)(STUT: GF6)(OTCQX: GIXEF) is pleased to announce the results of its Prefeasibility Study ("PFS" at its 100% owned Tepal Gold-Copper Project (the "Project" or "Tepal" in Mexico.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Acumen Pharmaceuticals to Showcase Innovations at Conference

Updated Category News Views 115

Acumen Pharmaceuticals to Present at Health Conference Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering clinical-stage biopharmaceutical company, is set to engage in a significant fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. This event will happen shortly, providing a platform for Acumen to discuss their innovative approaches to tackling...

Continue Reading
Chanson International Holding Reports Fiscal Year 2025 Mid-Year Results

Updated Category News Views 192

Chanson International Holding Reports Mid-Year Financial Results Chanson International Holding (NASDAQ: CHSN) has recently unveiled its financial performance for the first half of the fiscal year 2025. As a key player in the bakery and beverage sectors, the company's unaudited results signify its resilience in a fluctuating market. Overview of Financial Performance...

Continue Reading
Investors Are Strategically Analyzing REGN Options Activity

Updated Category News Views 66

Examining Recent Changes in REGN Options There's been a noteworthy shift in sentiment among financial experts regarding Regeneron Pharmaceuticals. A recent analysis of the trading patterns in REGN options has revealed a blend of bullish and bearish movements in the market. This information serves as a foundation for understanding the current factors that are shaping...

Continue Reading
Analysts Raise Price Targets for CVS After Strong Earning Report

Updated Category News Views 99

CVS Health Exceeds Expectations with Recent Earnings CVS Health Corp (NYSE: CVS) delivered an impressive earnings report for its fourth quarter, showing robust sales numbers that surpassed analysts' expectations. The company announced fourth-quarter sales totaling an incredible $97.71 billion, outpacing the consensus estimate of $97.19 billion. Adjusted Earnings Report...

Continue Reading
Healthcare Triangle and Teyame AI Join Forces to Innovate Patient Engagement

Updated Category News Views 161

Healthcare Triangle Announces Strategic Partnership with Teyame AI Healthcare Triangle, Inc. (Nasdaq: HCTI) is excited to share its recent agreement with Teyame AI LLC, a visionary corporation aiming to revolutionize customer experience through artificial intelligence. This partnership is a transformative step that will not only enhance HCTI's SaaS capabilities but is...

Continue Reading